Plus Therapeutics to Present at H.C. Wainwright Conference
![Plus Therapeutics to Present at H.C. Wainwright Conference](https://investorshangout.com/images/blog/ihnews-Plus%20Therapeutics%20to%20Present%20at%20H.C.%20Wainwright%20Conference.jpg)
Plus Therapeutics to Present at H.C. Wainwright Conference
AUSTIN, Texas — Plus Therapeutics, Inc. (Nasdaq: PSTV), a pioneering clinical-stage pharmaceutical company, is set to present a corporate overview at the H.C. Wainwright 26th Annual Global Investment Conference. This prestigious conference will occur at the Lotte New York Palace Hotel, running from September 9 to 11, 2024.
Presentation Details
Marc H. Hedrick, M.D., the President and Chief Executive Officer of Plus Therapeutics, will lead the presentation available on-demand starting Monday, September 9, at 7:00 AM ET.
Opportunities for Engagement
Management will be available for one-on-one meetings throughout the event. Interested parties can register for the conference to secure a meeting opportunity.
About Plus Therapeutics
Plus Therapeutics focuses on developing cutting-edge radiotherapeutics targeted for challenging cancers, particularly those affecting the central nervous system. The company combines advanced technologies such as image-guided local beta radiation with targeted drug delivery, aiming to significantly improve patient outcomes. Their leading programs are aimed at treating recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). With a strong leadership team and established partnerships, Plus Therapeutics is well-positioned for success in the oncology field. The company operates from key clinical development hubs in Texas, enhancing their capacity to innovate and deliver life-saving therapies.
Future Directions
With a proactive approach to research and development, Plus Therapeutics is committed to navigating the complexities of cancer treatment, continuously exploring new ways to apply their innovative tactics towards significant clinical advancements.
Frequently Asked Questions
What is Plus Therapeutics?
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company specializing in targeted radiotherapeutics for central nervous system cancers.
When is Plus Therapeutics presenting at the conference?
They will present at the H.C. Wainwright 26th Annual Global Investment Conference on September 9, 2024.
Who is presenting for Plus Therapeutics?
Marc H. Hedrick, M.D., the President and CEO, will lead the presentation.
What types of cancers does Plus Therapeutics target?
Plus Therapeutics primarily targets difficult-to-treat central nervous system cancers, including recurrent glioblastoma and leptomeningeal metastases.
How does Plus Therapeutics plan to enhance treatment outcomes?
They utilize a unique combination of image-guided beta radiation and targeted drug delivery to improve the efficacy and precision of cancer treatment.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- GlobalVetLink's Automation Tool Enhances Rabies Vaccine Management
- Randstad US Study: Political Conversations and Workplace Safety
- CIBC Mellon, UPP & IMCO to Host Investment Fund Conference
- Hackensack Meridian Health Foundation Gala Honors Eli Manning
- UK Investor Behavior: Shift from Stocks to Money Markets
- Apple's Anticipated 'Glowtime' Event to Unveil Innovations
- Rising Bankruptcy Filings in Commercial Sector Highlight Trends
- Metabolomics Technologies Market Set to Surge by 2034
- Brunswick Corporation Awarded Trustworthy Company Recognition
- Prepare for Safety: Michigan Church Security Conference 2024
- Myosin's Innovative Marketing Platform Redefines Advertising Impact
- Goya Foods Launches GOYA® Cares Hydrate for Hope Campaign
- Acer Introduces Eco-Friendly Vero PD2 Series LED Projectors
- Tower Arch Capital Partners with ACS Manufacturing for Growth
- Winking Studios Unveils GenMotion.AI for 3D Animation Innovation
- Norfolk Southern Signs Tentative Agreements with SMART-TD Unions
- Wells Fargo Advises Investors to Buy Election Weakness
- Tech Stocks Struggle Amid Economic Growth Concerns
- Blue Circle Health Launches New T1D Program in Northern States
- West Shore Home Appoints Al Patel as New Chief Marketing Officer
- Digestion Resistant Maltodextrin Market Set for Remarkable Growth
- Mid-Atlantic BioTherapeutics and Accelero Unite for Drug Discovery
- Peptide Therapeutics Market to Reach USD 85.9 Billion by 2031
- Saphyre and WTax Launch Innovative Tax Reclaim Solutions
- Steve Varsano Receives Aviator Award for Lifetime Achievement
Recent Articles
- Myosin's Innovative Marketing Platform Redefines Advertising Impact
- Digestion Resistant Maltodextrin Market Set for Remarkable Growth
- Mid-Atlantic BioTherapeutics and Accelero Unite for Drug Discovery
- Trillion Energy Reports Record Production and Revenue Growth
- Hedge Funds Show Resilience Amid Market Fluctuations in August
- AMD to Showcase Innovations at Goldman Sachs Event
- PennantPark Floating Rate Capital Ltd. Declares Monthly Dividend
- L'Oréal Paris Celebrates 10 Women Changing the World
- Acer Unveils Swift Go 14 AI and Swift 14 AI Laptops Boosting Productivity
- Aurigo Software Enhances Right of Way Solutions for Agencies
- FangDD Provides Important Updates on Substitution Listing
- 3D Systems Enhances Investment Casting with QuickCast Air™ Tool
- Fortress Biotech's Upcoming Presentation at Global Conference
- Reborn Coffee Expands Globally with Sichuan License Deal
- Mobile Dealer Data Introduces ServiceVision™ for Efficiency
- Volvo Cars Adjusts Electric Vehicle Goals Amid Market Changes
- Travel Retail Market: $152.61 Billion Growth by 2033
- Brandon XIV's Groundbreaking Spoken Word Poetry Album: One Year
- Osisko Gold Royalties Offers Insightful Asset Updates
- Psyence Biomed Partners with PsyLabs for Psilocybin Research
- Exploring Bull Steepening Cycles and Their Stock Impact
- atai Life Sciences to Showcase Innovations at Investment Conference
- Arbe Tier-1 Sensrad Secures Framework Agreement for 4D Imaging
- Berkshire Hathaway: Buffett's Vision and Future Considerations
- Top AI Stocks to Invest in for Future Growth Potential